GE Healthcare Introduces An Industry-First Modular, Scalable CT Platform to Minimize Technology Obsolescence & Maximize Clinical Capabilities
https://www.ge.com/news/ Read more
https://www.ge.com/news/ Read more
GE Healthcare introduces the industry’s first[i] computed tomography (CT) platform with built-in scalability and upgradability[ii] The new Revolution Apex platform offers the world’s fastest gantry speed: 0.23 seconds per rotation and 19.5 millisecond effective temporal resolution to freeze cardiac motion[iii] Altogether, the company’s CT platform enables healthcare facilities to keep up with the latest technology... Read more
Teams plan to cooperate on the development of a machine learning-based solution, aiming to improve care for cancer patients by giving cancer care teams access to complex data and information The potentially transformative solution will initially focus on ovarian cancer and will then expand for use in breast and kidney cancer. Cambridge/Chalfont St Giles, UK;... Read more
Infectious diseases, such as those infections transmitted via respiratory, sexually and transplant, are becoming increasingly difficult to manage and represent an ever-growing medical need for millions of patients worldwide. Access to accurate and reliable diagnostic tests help clinicians improve patient care, limit healthcare spending and contribute to protecting public health. The cobas 5800 System is... Read more
Photon counting CT has the promise to further expand the capabilities of traditional CT Karolinska Institutet and MedTechLabs’ pilot study represents the first of its kind to test pure silicon CT detector technology for photon counting CT in a clinical setting The project is the result of close collaborations between healthcare, academia and business Chicago,... Read more
Photon counting CT has the promise to further expand the capabilities of traditional CT Karolinska Institutet and MedTechLabs’ pilot study represents the first of its kind to test pure silicon CT detector technology for photon counting CT in a clinical setting The project is the result of close collaborations between healthcare, academia and business Chicago,... Read more
EU marketing authorisation follows approvals in Japan, the United Kingdom and Australia Approval based on data demonstrating Ronapreve reduced risk of hospitalisation in certain patients with mild to moderate disease and reduced risk of symptomatic COVID-19 infections in people exposed to the virus Basel, 12 November 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today... Read more
Recommendation based on data demonstrating Ronapreve reduced risk of hospitalisation in certain patients with mild to moderate disease and reduced risk of symptomatic COVID-19 infections in people exposed to the virus Ronapreve’s combination approach continues to retain neutralisation activity against variants of concern Basel, 11 November 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today... Read more
New IVD System Enables Assay Developers and Clinical Laboratories to Accelerate Molecular Diagnostics Growth Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow CARLSBAD, Calif., Nov. 9, 2021 /PRNewswire/ — As assay developers and clinical testing laboratories consider next steps for molecular diagnostics post-pandemic, a new in vitro diagnostic (IVD)... Read more